Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Abnormality of metabolism/homeostasis, Chronic mucocutaneous candidiasis, and Cutaneous anergy.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Metabolism | 1 | Abnormality of metabolism/homeostasis |
Biomarker and diagnostic research for chronic mucocutaneous candidiasis due to monocyte chemotactic disorder has been reported in the published literature.
No clinical trials have been registered for chronic mucocutaneous candidiasis due to monocyte chemotactic disorder.
102 publications have been identified in PubMed for chronic mucocutaneous candidiasis due to monocyte chemotactic disorder. Kisho has analyzed 72 by research type. Research spans Basic Science / Preclinical (51%), Epidemiology / Natural History (17%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 37 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:19 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about chronic mucocutaneous candidiasis due to monocyte chemotactic disorder
Disease patterns and progression | 12 | 17% |
Research summaries | 11 | 15% |
Testing and diagnosis research | 6 | 8% |
New treatment approaches | 3 | 4% |
Clinical study results | 2 | 3% |
Other research | 1 | 1% |
Luessi F (2026). [PMID: 41881460](https://pubmed.ncbi.nlm.nih.gov/41881460/). *Neurol Neuroimmunol Neuroinflamm*. [Basic Science / Preclinical]
Kaushal S (2026). [PMID: 41258851](https://pubmed.ncbi.nlm.nih.gov/41258851/). *JACC Heart Fail*. [Clinical Trial Publication]
Bittencourt JOA (2026). [PMID: 41412277](https://pubmed.ncbi.nlm.nih.gov/41412277/). *Life Sci*. [Basic Science / Preclinical]
Ramatchandirin B (2026). [PMID: 40962864](https://pubmed.ncbi.nlm.nih.gov/40962864/). *Pediatr Res*. [Basic Science / Preclinical]
Li Z (2026). [PMID: 40659086](https://pubmed.ncbi.nlm.nih.gov/40659086/). *J Adv Res*. [Gene Therapy / Novel Therapeutics]
Herdenberg S (2025). [PMID: 40152768](https://pubmed.ncbi.nlm.nih.gov/40152768/). *Cancer Prev Res (Phila)*. [Epidemiology / Natural History]
Lieh-Bang L (2025). [PMID: 40349124](https://pubmed.ncbi.nlm.nih.gov/40349124/). *Int J Rheum Dis*. [Other]
Huang Z (2025). [PMID: 40203120](https://pubmed.ncbi.nlm.nih.gov/40203120/). *Br J Dermatol*. [Basic Science / Preclinical]
Liu Y (2025). [PMID: 39725368](https://pubmed.ncbi.nlm.nih.gov/39725368/). *Respir Physiol Neurobiol*. [Basic Science / Preclinical]
Riaz M (2025). [PMID: 40091354](https://pubmed.ncbi.nlm.nih.gov/40091354/). *Innate Immun*. [Review / Meta-Analysis]